Nathan Johnson

Dr. Nathan Johnson

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
SRSteve Rodriguez
Steve Rodriguez
CHClemens Hug
Clemens Hug
PTPetar Todorov
Petar Todorov
NMNienke Moret
Nienke Moret
SBSarah A. Boswell
Sarah A. Boswell
ASArtem Sokolov
Artem Sokolov
Clinical trials of novel therapeutics for Alzheimer’s Disease (AD) have consumed a large amount of time and resources with largely negative results. Repurposing drugs already approved by the Food and Drug Administration (FDA) for another indication is a more rapid and less expensive option. We present DRIAD (Drug Repurposing In AD), a machine learning framework that quantifies potential associations between the pathology of AD severity (the Braak stage) and molecular mechanisms as encoded in lists of gene names. DRIAD is applied to lists of genes arising from perturbations in differentiated human neural cell cultures by 80 FDA-approved and clinically tested drugs, producing a ranked list of possible repurposing candidates. Top-scoring drugs are inspected for common trends among their targets. We propose that the DRIAD method can be used to nominate drugs that, after additional validation and identification of relevant pharmacodynamic biomarker(s), could be readily evaluated in a clinical trial.

14 December 2020 in Nature Cancer
Verified
Journal Article
Closed access
PDF file
AMAnita K. Mehta
Anita K. Mehta
ECEmily M. Cheney
Emily M. Cheney
CHChristina A. Hartl
Christina A. Hartl
CPConstantia Pantelidou
Constantia Pantelidou
MOMadisson Oliwa
Madisson Oliwa
JGJennifer Guerriero
Jennifer Guerriero

7 February 2019 in BMC Genomics
Verified
Journal Article
Open access
PDF file
RMRick E. Masonbrink
Rick E. Masonbrink
TMTom R. Maier
Tom R. Maier
UMUsha Muppirala
Usha Muppirala
ASArun S. Seetharam
Arun S. Seetharam
ELEtienne Lord
Etienne Lord
TBThomas J. Baum
Thomas J. Baum
Background: Heterodera glycines, commonly referred to as the soybean cyst nematode (SCN), is an obligatory and sedentary plant parasite that causes over a billion-dollar yield loss to soybean production annually. Although there are genetic determinants that render soybean plants resistant to certain nematode genotypes, resistant soybean cultivars are increasingly ineffective because their multi-year usage has selected for virulent H. glycines populations. The parasitic success of H. glycines relies on the comprehensive re-engineering of an infection site into a syncytium, as well as the long-term suppression of host defense to ensure syncytial viability. At the forefront of these complex molecular interactions are effectors, the proteins secreted by H. glycines into host root tissues. The mechanisms of effector acquisition, diversification, and selection need to be understood before effective control strategies can be developed, but the lack of an annotated genome has been a major roadblock. Results: Here, we use PacBio long-read technology to assemble a H. glycines genome of 738 contigs into 123 Mb with annotations for 29,769 genes. The genome contains significant numbers of repeats (34%), tandem duplicates (18.7 Mb), and horizontal gene transfer events (151 genes). A large number of putative effectors (431 genes) were identified in the genome, many of which were found in transposons. Conclusions: This advance provides a glimpse into the host and parasite interplay by revealing a diversity of mechanisms that give rise to virulence genes in the soybean cyst nematode, including: tandem duplications containing over a fifth of the total gene count, virulence genes hitchhiking in transposons, and 107 horizontal gene transfers not reported in other plant parasitic nematodes thus far. Through extensive characterization of the H. glycines genome, we provide new insights into H. glycines biology and shed light onto the mystery underlying complex host-parasite interactions. This genome sequence is an important prerequisite to enable work towards generating new resistance or control measures against H. glycines.

19 June 2015 in Epigenetics
Verified
Journal Article
Open access
ALAlmamun
Almamun
BLBenjamin T Levinson
Benjamin T Levinson
ASAnnette C van Swaay
Annette C van Swaay
NJNathan Johnson
Nathan Johnson
Stephanie McKayStephanie McKay
Stephanie McKay
KTKristen H Taylor
Kristen H Taylor
Acute lymphoblastic leukemia (ALL) is the most common cancer diagnosed in children under the age of 15. In addition to genetic aberrations, epigenetic modifications such as DNA methylation are altered in cancer and impact gene expression. To identify epigenetic alterations in ALL, genome-wide methylation profiles were generated using the methylated CpG island recovery assay followed by next-generation sequencing. More than 25,000 differentially methylated regions (DMR) were observed in ALL patients with ∼90% present within intronic or intergenic regions. To determine the regulatory potential of the DMR, whole-transcriptome analysis was performed and integrated with methylation data. Aberrant promoter methylation was associated with the altered expression of genes involved in transcriptional regulation, apoptosis, and proliferation. Novel enhancer-like sequences were identified within intronic and intergenic DMR. Aberrant methylation in these regions was associated with the altered expression of neighboring genes involved in cell cycle processes, lymphocyte activation and apoptosis. These genes include potential epi-driver genes, such as SYNE1, PTPRS, PAWR, HDAC9, RGCC, MCOLN2, LYN, TRAF3, FLT1, and MELK, which may provide a selective advantage to leukemic cells. In addition, the differential expression of epigenetic modifier genes, pseudogenes, and non-coding RNAs was also observed accentuating the role of erroneous epigenetic gene regulation in ALL.

25 June 2018 in RNA
Verified
Journal Article
Open access
PDF file
NJNathan Johnson
Nathan Johnson
ADAndi Dhroso
Andi Dhroso
KHKatelyn J. Hughes
Katelyn J. Hughes
DKDmitry Korkin
Dmitry Korkin
RNA sequencing (RNA-seq) is becoming a prevalent approach to quantify gene expression and is expected to gain better insights into a number of biological and biomedical questions compared to DNA microarrays. Most importantly, RNA-seq allows us to quantify expression at the gene or transcript levels. However, leveraging the RNA-seq data requires development of new data mining and analytics methods. Supervised learning methods are commonly used approaches for biological data analysis that have recently gained attention for their applications to RNA-seq data. Here, we assess the utility of supervised learning methods trained on RNA-seq data for a diverse range of biological classification tasks. We hypothesize that the transcript-level expression data are more informative for biological classification tasks than the gene-level expression data. Our large-scale assessment utilizes multiple data sets, organisms, lab groups, and RNA-seq analysis pipelines. Overall, we performed and assessed 61 biological classification problems that leverage three independent RNA-seq data sets and include over 2000 samples that come from multiple organisms, lab groups, and RNA-seq analyses. These 61 problems include predictions of the tissue type, sex, or age of the sample, healthy or cancerous phenotypes, and pathological tumor stages for the samples from the cancerous tissue. For each problem, the performance of three normalization techniques and six machine learning classifiers was explored. We find that for every single classification problem, the transcript-based classifiers outperform or are comparable with gene expression-based methods. The top-performing techniques reached a near perfect classification accuracy, demonstrating the utility of supervised learning for RNA-seq based data analysis.

6 February 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MGMichael Gardner
Michael Gardner
ADAndi Dhroso
Andi Dhroso
NJNathan Johnson
Nathan Johnson
EDEric L. Davis
Eric L. Davis
TBThomas J. Baum
Thomas J. Baum
MMMelissa G. Mitchum
Melissa G. Mitchum
Soybean cyst nematode (SCN) Heterodera glycines is an obligate parasite that relies on the secretion of effector proteins to manipulate host cellular processes that favor the formation of a feeding site within host roots to ensure its survival. The sequence complexity and co-evolutionary forces acting upon these effectors remain unknown. Here we generated a de novo transcriptome assembly representing the early life stages of SCN in both a compatible and an incompatible host interaction to facilitate global effector mining efforts in the absence of an available annotated SCN genome. We then employed a dual effector prediction strategy coupling a newly developed nematode effector prediction tool, N-Preffector, with a traditional secreted protein prediction pipeline to uncover a suite of novel effector candidates. Our analysis distinguished between effectors that co-evolve with the host genotype and those conserved by the pathogen to maintain a core function in parasitism and demonstrated that alternative splicing is one mechanism used to diversify the effector pool. In addition, we confirmed the presence of viral and microbial inhabitants with molecular sequence information. This transcriptome represents the most comprehensive whole-nematode sequence currently available for SCN and can be used as a tool for annotation of expected genome assemblies.